Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Antigenic cartography of immune responses to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1).

Tuju J, Mackinnon MJ, Abdi AI, Karanja H, Musyoki JN, Warimwe GM, Gitau EN, Marsh K, Bull PC, Urban BC.

PLoS Pathog. 2019 Jul 1;15(7):e1007870. doi: 10.1371/journal.ppat.1007870. eCollection 2019 Jul. Erratum in: PLoS Pathog. 2019 Aug 15;15(8):e1008018.

2.

Recent advances in the molecular epidemiology of clinical malaria.

Recker M, Bull PC, Buckee CO.

F1000Res. 2018 Jul 30;7. pii: F1000 Faculty Rev-1159. doi: 10.12688/f1000research.14991.1. eCollection 2018. Review.

3.

Long read assemblies of geographically dispersed Plasmodium falciparum isolates reveal highly structured subtelomeres.

Otto TD, Böhme U, Sanders M, Reid A, Bruske EI, Duffy CW, Bull PC, Pearson RD, Abdi A, Dimonte S, Stewart LB, Campino S, Kekre M, Hamilton WL, Claessens A, Volkman SK, Ndiaye D, Amambua-Ngwa A, Diakite M, Fairhurst RM, Conway DJ, Franck M, Newbold CI, Berriman M.

Wellcome Open Res. 2018 May 3;3:52. doi: 10.12688/wellcomeopenres.14571.1. eCollection 2018.

4.

Plasmodium falciparum variant erythrocyte surface antigens: a pilot study of antibody acquisition in recurrent natural infections.

Schieck E, Poole EJ, Rippert A, Peshu J, Sasi P, Borrmann S, Bull PC.

Malar J. 2017 Nov 7;16(1):450. doi: 10.1186/s12936-017-2097-0.

5.

A re-assessment of gene-tag classification approaches for describing var gene expression patterns during human Plasmodium falciparum malaria parasite infections.

Githinji G, Bull PC.

Wellcome Open Res. 2017 Sep 19;2:86. doi: 10.12688/wellcomeopenres.12053.1. eCollection 2017.

6.

Public antibodies to malaria antigens generated by two LAIR1 insertion modalities.

Pieper K, Tan J, Piccoli L, Foglierini M, Barbieri S, Chen Y, Silacci-Fregni C, Wolf T, Jarrossay D, Anderle M, Abdi A, Ndungu FM, Doumbo OK, Traore B, Tran TM, Jongo S, Zenklusen I, Crompton PD, Daubenberger C, Bull PC, Sallusto F, Lanzavecchia A.

Nature. 2017 Aug 31;548(7669):597-601. doi: 10.1038/nature23670. Epub 2017 Aug 23.

7.

Plasmodium falciparum malaria parasite var gene expression is modified by host antibodies: longitudinal evidence from controlled infections of Kenyan adults with varying natural exposure.

Abdi AI, Hodgson SH, Muthui MK, Kivisi CA, Kamuyu G, Kimani D, Hoffman SL, Juma E, Ogutu B, Draper SJ, Osier F, Bejon P, Marsh K, Bull PC.

BMC Infect Dis. 2017 Aug 23;17(1):585. doi: 10.1186/s12879-017-2686-0.

8.

A single point in protein trafficking by Plasmodium falciparum determines the expression of major antigens on the surface of infected erythrocytes targeted by human antibodies.

Chan JA, Howell KB, Langer C, Maier AG, Hasang W, Rogerson SJ, Petter M, Chesson J, Stanisic DI, Duffy MF, Cooke BM, Siba PM, Mueller I, Bull PC, Marsh K, Fowkes FJ, Beeson JG.

Cell Mol Life Sci. 2016 Nov;73(21):4141-58. doi: 10.1007/s00018-016-2267-1. Epub 2016 May 19.

9.

Serological Conservation of Parasite-Infected Erythrocytes Predicts Plasmodium falciparum Erythrocyte Membrane Protein 1 Gene Expression but Not Severity of Childhood Malaria.

Warimwe GM, Abdi AI, Muthui M, Fegan G, Musyoki JN, Marsh K, Bull PC.

Infect Immun. 2016 Apr 22;84(5):1331-1335. doi: 10.1128/IAI.00772-15. Print 2016 May.

10.

Global selection of Plasmodium falciparum virulence antigen expression by host antibodies.

Abdi AI, Warimwe GM, Muthui MK, Kivisi CA, Kiragu EW, Fegan GW, Bull PC.

Sci Rep. 2016 Jan 25;6:19882. doi: 10.1038/srep19882.

11.

The role of PfEMP1 as targets of naturally acquired immunity to childhood malaria: prospects for a vaccine.

Bull PC, Abdi AI.

Parasitology. 2016 Feb;143(2):171-86. doi: 10.1017/S0031182015001274. Epub 2016 Jan 7. Review.

12.

Differential Plasmodium falciparum surface antigen expression among children with Malarial Retinopathy.

Abdi AI, Kariuki SM, Muthui MK, Kivisi CA, Fegan G, Gitau E, Newton CR, Bull PC.

Sci Rep. 2015 Dec 14;5:18034. doi: 10.1038/srep18034.

13.

Agglutination Assays of the Plasmodium falciparum-Infected Erythrocyte.

Tan J, Bull PC.

Methods Mol Biol. 2015;1325:115-29. doi: 10.1007/978-1-4939-2815-6_10.

14.

Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection.

Hodgson SH, Juma E, Salim A, Magiri C, Kimani D, Njenga D, Muia A, Cole AO, Ogwang C, Awuondo K, Lowe B, Munene M, Billingsley PF, James ER, Gunasekera A, Sim BK, Njuguna P, Rampling TW, Richman A, Abebe Y, Kamuyu G, Muthui M, Elias SC, Molyneux S, Gerry S, Macharia A, Williams TN, Bull PC, Hill AV, Osier FH, Draper SJ, Bejon P, Hoffman SL, Ogutu B, Marsh K.

Front Microbiol. 2014 Dec 12;5:686. doi: 10.3389/fmicb.2014.00686. eCollection 2014.

15.

Measuring soluble ICAM-1 in African populations.

Abdi AI, Muthui M, Kiragu E, Bull PC.

PLoS One. 2014 Oct 7;9(10):e108956. doi: 10.1371/journal.pone.0108956. eCollection 2014.

16.

An assessment of the impact of host polymorphisms on Plasmodium falciparum var gene expression patterns among Kenyan children.

Warimwe GM, Fegan G, Kiragu EW, Musyoki JN, Macharia AW, Marsh K, Williams TN, Bull PC.

BMC Infect Dis. 2014 Sep 29;14:524. doi: 10.1186/1471-2334-14-524.

17.

Plasmodium falciparum antigenic variation: relationships between widespread endothelial activation, parasite PfEMP1 expression and severe malaria.

Abdi AI, Fegan G, Muthui M, Kiragu E, Musyoki JN, Opiyo M, Marsh K, Warimwe GM, Bull PC.

BMC Infect Dis. 2014 Mar 28;14:170. doi: 10.1186/1471-2334-14-170.

18.

Plasmodium falciparum var gene expression homogeneity as a marker of the host-parasite relationship under different levels of naturally acquired immunity to malaria.

Warimwe GM, Recker M, Kiragu EW, Buckee CO, Wambua J, Musyoki JN, Marsh K, Bull PC.

PLoS One. 2013 Jul 29;8(7):e70467. doi: 10.1371/journal.pone.0070467. Print 2013.

19.

Targets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunity.

Chan JA, Howell KB, Reiling L, Ataide R, Mackintosh CL, Fowkes FJ, Petter M, Chesson JM, Langer C, Warimwe GM, Duffy MF, Rogerson SJ, Bull PC, Cowman AF, Marsh K, Beeson JG.

J Clin Invest. 2012 Sep;122(9):3227-38. doi: 10.1172/JCI62182. Epub 2012 Aug 1.

20.

A subset of group A-like var genes encodes the malaria parasite ligands for binding to human brain endothelial cells.

Claessens A, Adams Y, Ghumra A, Lindergard G, Buchan CC, Andisi C, Bull PC, Mok S, Gupta AP, Wang CW, Turner L, Arman M, Raza A, Bozdech Z, Rowe JA.

Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):E1772-81. doi: 10.1073/pnas.1120461109. Epub 2012 May 22.

21.

A restricted subset of var genes mediates adherence of Plasmodium falciparum-infected erythrocytes to brain endothelial cells.

Avril M, Tripathi AK, Brazier AJ, Andisi C, Janes JH, Soma VL, Sullivan DJ Jr, Bull PC, Stins MF, Smith JD.

Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):E1782-90. doi: 10.1073/pnas.1120534109. Epub 2012 May 22.

22.

Induction of strain-transcending antibodies against Group A PfEMP1 surface antigens from virulent malaria parasites.

Ghumra A, Semblat JP, Ataide R, Kifude C, Adams Y, Claessens A, Anong DN, Bull PC, Fennell C, Arman M, Amambua-Ngwa A, Walther M, Conway DJ, Kassambara L, Doumbo OK, Raza A, Rowe JA.

PLoS Pathog. 2012;8(4):e1002665. doi: 10.1371/journal.ppat.1002665. Epub 2012 Apr 19.

23.

Prognostic indicators of life-threatening malaria are associated with distinct parasite variant antigen profiles.

Warimwe GM, Fegan G, Musyoki JN, Newton CR, Opiyo M, Githinji G, Andisi C, Menza F, Kitsao B, Marsh K, Bull PC.

Sci Transl Med. 2012 Apr 11;4(129):129ra45. doi: 10.1126/scitranslmed.3003247.

24.

T-cell responses to the DBLα-tag, a short semi-conserved region of the Plasmodium falciparum membrane erythrocyte protein 1.

Gitau EN, Tuju J, Stevenson L, Kimani E, Karanja H, Marsh K, Bull PC, Urban BC.

PLoS One. 2012;7(1):e30095. doi: 10.1371/journal.pone.0030095. Epub 2012 Jan 17.

25.

Serological evidence of discrete spatial clusters of Plasmodium falciparum parasites.

Bejon P, Turner L, Lavstsen T, Cham G, Olotu A, Drakeley CJ, Lievens M, Vekemans J, Savarese B, Lusingu J, von Seidlein L, Bull PC, Marsh K, Theander TG.

PLoS One. 2011;6(6):e21711. doi: 10.1371/journal.pone.0021711. Epub 2011 Jun 29.

26.

Specific receptor usage in Plasmodium falciparum cytoadherence is associated with disease outcome.

Ochola LB, Siddondo BR, Ocholla H, Nkya S, Kimani EN, Williams TN, Makale JO, Liljander A, Urban BC, Bull PC, Szestak T, Marsh K, Craig AG.

PLoS One. 2011 Mar 3;6(3):e14741. doi: 10.1371/journal.pone.0014741.

27.

Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria.

Osier FH, Murungi LM, Fegan G, Tuju J, Tetteh KK, Bull PC, Conway DJ, Marsh K.

Parasite Immunol. 2010 Mar;32(3):193-201. doi: 10.1111/j.1365-3024.2009.01178.x.

28.

Plasmodium falciparum var gene expression is modified by host immunity.

Warimwe GM, Keane TM, Fegan G, Musyoki JN, Newton CR, Pain A, Berriman M, Marsh K, Bull PC.

Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21801-6. doi: 10.1073/pnas.0907590106. Epub 2009 Dec 11.

29.
30.

Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure.

Bejon P, Warimwe G, Mackintosh CL, Mackinnon MJ, Kinyanjui SM, Musyoki JN, Bull PC, Marsh K.

Infect Immun. 2009 May;77(5):1917-23. doi: 10.1128/IAI.01358-08. Epub 2009 Feb 17. Erratum in: Infect Immun. 2011 Apr;79(4):1804.

31.

Inferring malaria parasite population structure from serological networks.

Buckee CO, Bull PC, Gupta S.

Proc Biol Sci. 2009 Feb 7;276(1656):477-85. doi: 10.1098/rspb.2008.1122.

32.

Plasmodium falciparum antigenic variation. Mapping mosaic var gene sequences onto a network of shared, highly polymorphic sequence blocks.

Bull PC, Buckee CO, Kyes S, Kortok MM, Thathy V, Guyah B, Stoute JA, Newbold CI, Marsh K.

Mol Microbiol. 2008 Jun;68(6):1519-34. doi: 10.1111/j.1365-2958.2008.06248.x. Epub 2008 Apr 21.

33.

Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.

Osier FH, Fegan G, Polley SD, Murungi L, Verra F, Tetteh KK, Lowe B, Mwangi T, Bull PC, Thomas AW, Cavanagh DR, McBride JS, Lanar DE, Mackinnon MJ, Conway DJ, Marsh K.

Infect Immun. 2008 May;76(5):2240-8. doi: 10.1128/IAI.01585-07. Epub 2008 Mar 3.

34.

Haemoglobin C and S role in acquired immunity against Plasmodium falciparum malaria.

Verra F, Simpore J, Warimwe GM, Tetteh KK, Howard T, Osier FH, Bancone G, Avellino P, Blot I, Fegan G, Bull PC, Williams TN, Conway DJ, Marsh K, Modiano D.

PLoS One. 2007 Oct 3;2(10):e978.

35.

An approach to classifying sequence tags sampled from Plasmodium falciparum var genes.

Bull PC, Kyes S, Buckee CO, Montgomery J, Kortok MM, Newbold CI, Marsh K.

Mol Biochem Parasitol. 2007 Jul;154(1):98-102. Epub 2007 Mar 25. No abstract available.

36.

In vitro inhibition of Plasmodium falciparum rosette formation by Curdlan sulfate.

Kyriacou HM, Steen KE, Raza A, Arman M, Warimwe G, Bull PC, Havlik I, Rowe JA.

Antimicrob Agents Chemother. 2007 Apr;51(4):1321-6. Epub 2007 Feb 5.

37.

The frequency of BDCA3-positive dendritic cells is increased in the peripheral circulation of Kenyan children with severe malaria.

Urban BC, Cordery D, Shafi MJ, Bull PC, Newbold CI, Williams TN, Marsh K.

Infect Immun. 2006 Dec;74(12):6700-6. Epub 2006 Sep 25.

38.

Plasmodium falciparum variant surface antigen expression patterns during malaria.

Bull PC, Berriman M, Kyes S, Quail MA, Hall N, Kortok MM, Marsh K, Newbold CI.

PLoS Pathog. 2005 Nov;1(3):e26. Epub 2005 Nov 18.

39.

Longevity of the immune response and memory to blood-stage malaria infection.

Achtman AH, Bull PC, Stephens R, Langhorne J.

Curr Top Microbiol Immunol. 2005;297:71-102. Review.

PMID:
16265903
40.

Plasmodium falciparum antigenic variation: relationships between in vivo selection, acquired antibody response, and disease severity.

Bull PC, Pain A, Ndungu FM, Kinyanjui SM, Roberts DJ, Newbold CI, Marsh K.

J Infect Dis. 2005 Sep 15;192(6):1119-26. Epub 2005 Aug 12. Erratum in: J Infect Dis. 2005 Nov 1;192(9):1678.

PMID:
16107968
41.
42.

The use of cryopreserved mature trophozoites in assessing antibody recognition of variant surface antigens of Plasmodium falciparum-infected erythrocytes.

Kinyanjui SM, Howard T, Williams TN, Bull PC, Newbold CI, Marsh K.

J Immunol Methods. 2004 May;288(1-2):9-18.

PMID:
15183081
43.

Transient cross-reactive immune responses can orchestrate antigenic variation in malaria.

Recker M, Nee S, Bull PC, Kinyanjui S, Marsh K, Newbold C, Gupta S.

Nature. 2004 Jun 3;429(6991):555-8.

PMID:
15175751
44.

Plasmodium falciparum infections are associated with agglutinating antibodies to parasite-infected erythrocyte surface antigens among healthy Kenyan children.

Bull PC, Lowe BS, Kaleli N, Njuga F, Kortok M, Ross A, Ndungu F, Snow RW, Marsh K.

J Infect Dis. 2002 Jun 1;185(11):1688-91. Epub 2002 May 17. Erratum in: J Infect Dis. 2010 Jun 1;201(11):1780.

PMID:
12023781
46.
47.

Plasmodium falciparum-infected erythrocytes: agglutination by diverse Kenyan plasma is associated with severe disease and young host age.

Bull PC, Kortok M, Kai O, Ndungu F, Ross A, Lowe BS, Newbold CI, Marsh K.

J Infect Dis. 2000 Jul;182(1):252-9. Epub 2000 Jun 30. Erratum in: J Infect Dis 2000 Aug;182(2):641.

PMID:
10882604
48.
49.

All four species of human malaria parasites form rosettes.

Lowe BS, Mosobo M, Bull PC.

Trans R Soc Trop Med Hyg. 1998 Sep-Oct;92(5):526. No abstract available.

PMID:
9861369
50.

Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria.

Bull PC, Lowe BS, Kortok M, Molyneux CS, Newbold CI, Marsh K.

Nat Med. 1998 Mar;4(3):358-60.

Supplemental Content

Support Center